Innovative Detection Technology Neurosteer offers advanced EEG-based wearable solutions that enable early detection of neurological disorders such as Parkinson's, Alzheimer’s, dementia, and epilepsy, presenting opportunities to integrate with hospitals, clinics, and research centers focused on neurodiagnostics.

Award-Winning Credibility Having received multiple 'Brain Health Company of the Year' awards, Neurosteer has established a strong reputation which can facilitate trust and credibility when approaching healthcare providers and investors interested in pioneering neurotechnology.

Growing Funding & Market Presence With $4.5 million in funding and a focus on continuous innovation, Neurosteer is positioned for expansion into new markets and partnerships within the neurodiagnostic and clinical trial sectors, opening avenues for collaborative opportunities.

Advanced Data Analytics The company’s use of sophisticated algorithms that decompose EEG signals into multiple components allows for more accurate and real-time neurological assessments, appealing to research institutions and pharmaceutical companies seeking precise biomarkers for clinical trials.

Focus on Neurohealth Innovation Neurosteer’s emphasis on affordable, continuous patient monitoring and neurostimulation enhances its appeal to healthcare providers seeking to improve treatment outcomes and patient engagement in neurodegenerative and neurological disorder management.